One question, as a layman, I would like to ask Coates is why is it that inserting the islets into a new vascularised bed formed by the introduction of BTM is a better option that inserting the islets into the patients existing dermis? Maybe it's a rejection issue. Any thoughts from the more educated here?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
-0.008(0.62%) |
Mkt cap ! $837.6M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.19 | $1.533M | 1.278M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 2942 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 29388 | 23 |
View Market Depth
| Last trade - 15.02pm 18/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |